Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GS-9667是一种A(1)腺苷受体(AR)的选择性部分激动剂,通过降低游离脂肪酸(FFA)可有效治疗2型糖尿病(T2DM)和血脂异常。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 930 | 现货 | ||
5 mg | ¥ 2,230 | 现货 | ||
10 mg | ¥ 3,320 | 现货 | ||
25 mg | ¥ 5,420 | 现货 | ||
50 mg | ¥ 7,590 | 现货 | ||
100 mg | ¥ 9,870 | 现货 | ||
500 mg | ¥ 19,800 | 现货 |
产品描述 | GS-9667, a selective and partial agonist of the A(1) adenosine receptor (AR), represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA). |
体内活性 | In the single ascending dose study, healthy, non-obese, and obese subjects received GS-9667 (30-1,800 mg; oral; single dose). In the multiple, ascending dose study, healthy, obese subjects received GS-9667 (600-2,400 mg QD, 1,200 mg BID, or 600 mg QID) for 14 days. Doses of GS-9667 ≥300 mg caused dose-dependent reductions in FFA levels that were reproducible over 14 days without evidence of desensitization or rebound. All doses were well tolerated. GS-9667 was rapidly absorbed and distributed; Steady-state concentrations were achieved within 3-5 days. The A(1) AR partial agonist GS-9667 reduced plasma FFA, exhibited linear kinetics, and was well-tolerated in healthy non-obese and obese subjects.[1] |
别名 | CVT-3619, CVT 3619 |
分子量 | 461.51 |
分子式 | C21H24FN5O4S |
CAS No. | 618380-90-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (119.17 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.1668 mL | 10.834 mL | 21.668 mL | 54.17 mL |
5 mM | 0.4334 mL | 2.1668 mL | 4.3336 mL | 10.834 mL | |
10 mM | 0.2167 mL | 1.0834 mL | 2.1668 mL | 5.417 mL | |
20 mM | 0.1083 mL | 0.5417 mL | 1.0834 mL | 2.7085 mL | |
50 mM | 0.0433 mL | 0.2167 mL | 0.4334 mL | 1.0834 mL | |
100 mM | 0.0217 mL | 0.1083 mL | 0.2167 mL | 0.5417 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
GS-9667 618380-90-8 GPCR/G Protein Neuroscience Adenosine Receptor CVT3619 CVT-3619 CVT 3619 GS9667 GS 9667 Inhibitor inhibitor inhibit